Microbio appoints Colin Keating as CEO

Brisbane, 24 October 2023 – Microbio Ltd, an Australian molecular pathogen diagnostics company, is pleased to announce the appointment of Colin Keating as CEO, effective from 1 November 2023. Mr Keating joined Microbio as interim COO in May and assumed the role of interim CEO in early June. Mr Keating’s experience delivering transformation programs at… Continue reading Microbio appoints Colin Keating as CEO

Microbio featured on Smart Company

Microbio has been featured by Smart Company in an article highlighting the commercialisation of InfectID-BSI and how it has benefitted from our participation in the Brisbane Economic Development Agency’s MedTech Accelerator program. Microbio develops pathogen test to identify and treat sepsis (smartcompany.com.au)

September is Sepsis Awareness Month

September is sepsis awareness month

Every September the world marks Sepsis Awareness Month. This year Microbio celebrates the incredible work undertaken by sepsis organisations around the world, who are raising awareness, advocating for survivors and improving sepsis management. Follow us on LinkedIn and X to find out the latest statistics, learn the signs and read the stories of sepsis patients… Continue reading September is Sepsis Awareness Month

Published
Categorised as Blog post

Microbio appoints Jeff Bryant to drive global commercial strategy

Jeff Bryant

Microbio Ltd, an Australian pathogen detection diagnostics company, is pleased to announce the appointment of Jeff Bryant as its Commercial Director. Mr Bryant will lead the company’s commercial team as it executes its global commercialisation strategy. With his extensive experience in market entry strategy, sales growth, and sales channel development, Mr Bryant brings valuable expertise… Continue reading Microbio appoints Jeff Bryant to drive global commercial strategy